Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs BACIL PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES BACIL PHARMA DIVIS LABORATORIES/
BACIL PHARMA
 
P/E (TTM) x 31.9 -1.0 - View Chart
P/BV x 8.4 2.9 291.1% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 DIVIS LABORATORIES   BACIL PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
BACIL PHARMA
Mar-21
DIVIS LABORATORIES/
BACIL PHARMA
5-Yr Chart
Click to enlarge
High Rs5,4256 88,643.8%   
Low Rs3,5622 226,882.2%   
Sales per share (Unadj.) Rs337.50-  
Earnings per share (Unadj.) Rs111.5-0.4 -27,482.7%  
Cash flow per share (Unadj.) Rs123.3-0.4 -31,023.6%  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %0.70-  
Book value per share (Unadj.) Rs441.82.4 18,707.0%  
Shares outstanding (eoy) m265.475.89 4,507.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.30-  
Avg P/E ratio x40.3-9.5 -425.7%  
P/CF ratio (eoy) x36.5-9.7 -377.1%  
Price / Book Value ratio x10.21.6 624.8%  
Dividend payout %26.90-   
Avg Mkt Cap Rs m1,192,89023 5,267,203.0%   
No. of employees `000NANA-   
Total wages/salary Rs m9,4621 1,819,538.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,5980-  
Other income Rs m1,1591 156,621.6%   
Total revenues Rs m90,7571 12,264,500.0%   
Gross profit Rs m38,811-3 -1,276,680.9%  
Depreciation Rs m3,1150 6,230,200.0%   
Interest Rs m200 40,000.0%   
Profit before tax Rs m36,835-2 -1,534,791.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2310-   
Profit after tax Rs m29,605-2 -1,238,682.0%  
Gross profit margin %43.30- 
Effective tax rate %19.60.2 10,956.0%   
Net profit margin %33.00- 
BALANCE SHEET DATA
Current assets Rs m96,1043 3,182,248.3%   
Current liabilities Rs m24,54427 91,006.3%   
Net working cap to sales %79.90- 
Current ratio x3.90.1 3,496.7%  
Inventory Days Days90- 
Debtors Days Days9870- 
Net fixed assets Rs m50,08737 136,144.1%   
Share capital Rs m53165 813.4%   
"Free" reserves Rs m116,751-51 -227,318.7%   
Net worth Rs m117,28214 843,147.4%   
Long term debt Rs m00-   
Total assets Rs m146,19140 367,222.6%  
Interest coverage x1,842.8-47.0 -3,920.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60-   
Return on assets %20.3-5.9 -343.9%  
Return on equity %25.2-17.2 -146.8%  
Return on capital %31.4-16.9 -186.0%  
Exports to sales %00-  
Imports to sales %19.70-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs m17,676NA-   
Fx inflow Rs m78,4450-   
Fx outflow Rs m17,9530-   
Net fx Rs m60,4920-   
CASH FLOW
From Operations Rs m19,118-4 -480,351.8%  
From Investments Rs m-21,9495 -415,704.5%  
From Financial Activity Rs m-5,324-1 729,369.9%  
Net Cashflow Rs m-8,1561 -1,456,357.1%  

Share Holding

Indian Promoters % 51.9 42.7 121.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.5 0.0 -  
FIIs % 16.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 57.3 83.8%  
Shareholders   346,905 6,545 5,300.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    



Today's Market

Sensex Zooms 130 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian benchmark indices ended on a positive note amid a highly volatile session. This was on the back of metal stocks along with banking and financials.